An investigative peptide-acyclovir combination to control herpes simplex virus type 1 ocular infection.
An investigative peptide-acyclovir combination to control herpes simplex virus type 1 ocular infection. Invest Ophthalmol Vis Sci. 2013 Sep 27; 54(9):6373-81.